MetLife Inc. stock holds firm as Wall Street Zen cuts rating to Hold

Published on 09/19/2026 at 20:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife Inc. stock trades close to analyst price targets after Wall Street Zen downgraded the shares to Hold on September 19, 2026. Recent earnings showed double-digit revenue growth and an earnings beat alongside a new USD 3 billion buyback plan.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund — Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. stock (ISIN US59156R1086) is trading close to its consensus analyst price target after Wall Street Zen lowered its rating on the shares to Hold on September 19, 2026, even as the insurer recently delivered double-digit revenue growth and an earnings beat for its latest quarter.

Rating downgrade contrasts with earnings strength

According to MarketBeat on September 19, 2026, research platform Wall Street Zen downgraded MetLife from Buy to Hold while the broader analyst consensus on the stock remains Moderate Buy, with 11 Buy ratings and a consensus price target of USD 102.77.

As MarketBeat reports, MetLife posted quarterly earnings per share of USD 2.43, beating the consensus estimate of USD 2.30 by USD 0.13, while revenue for the same quarter rose 10.5 percent year over year to USD 13.52 billion, underscoring solid operational momentum.

Buyback and analyst targets support valuation

According to MarketBeat, MetLife's board has authorized a share repurchase program of up to USD 3 billion, equivalent to around 4.8 percent of the company's outstanding shares, which provides additional support for the stock and signals confidence in future cash generation.

MarketBeat's detailed overview on September 18, 2026 shows that MetLife carries an average analyst price target of USD 102.77, with a high target of USD 111.00 and a low of USD 90.00, implying around 5.8 percent potential upside from recent trading levels for the consensus view, while still leaving some room for differing opinions on valuation among individual houses, as reported by MarketBeat.

Stock trades just below recent highs

Shares of MetLife opened at around USD 97.08 on the New York Stock Exchange on September 18, 2026, according to pricing data cited in the analyst overview from MarketBeat, placing the stock only a few percent below the consensus target of USD 102.77 and close to recent 52-week highs reported in the same data set.

Earlier in September 2026, MetLife Inc. stock closed at USD 95.69 on the New York Stock Exchange on September 9, 2026, about 5 percent below a cited 52-week high of USD 100.93 and roughly 42 percent above the 52-week low of USD 67.33, illustrating how the shares have climbed substantially over the past year while still trading modestly below their peak, as noted by a MarketBeat-based analysis published on September 18, 2026.

Investor takeaway: earnings beat versus valuation caution

The combination of an EPS beat of USD 0.13 versus consensus in the latest reported quarter, a 10.5 percent year-over-year revenue increase to USD 13.52 billion and a newly authorized USD 3 billion buyback program presents a fundamentally supportive backdrop for MetLife Inc. stock, according to the data compiled by MarketBeat.

At the same time, Wall Street Zen's decision to lower its rating from Buy to Hold, as reported through MarketBeat on September 19, 2026, highlights valuation considerations, with the shares already trading near the USD 102.77 consensus target and some analysts evidently seeing less clear upside at current levels.